Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aaron Dou

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|June 4, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapyMitchell J Elliott, Jesús Fuentes-Antrás, Sasha C Main, et al.
Nature Communications|February 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assayMitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas, et al.
NPJ Precision Oncology|June 3, 2026
Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancerChristopher Pretz, Jesús Fuentes-Antrás, Sasha Main, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast CancerMitchell J Elliott, Karen Howarth, Sasha Main, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Nature Communications|June 4, 2026
Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapyMitchell J Elliott, Jesús Fuentes-Antrás, Sasha C Main, et al.
Nature Communications|February 21, 2025
Longitudinal evaluation of circulating tumor DNA in patients undergoing neoadjuvant therapy for early breast cancer using a tumor-informed assayMitchell J Elliott, Philippe Echelard, Christodoulos Pipinikas, et al.
NPJ Precision Oncology|June 3, 2026
Longitudinal evaluation of serial ctDNA kinetics using joint modeling in patients with metastatic breast cancerChristopher Pretz, Jesús Fuentes-Antrás, Sasha Main, et al.
NPJ Breast Cancer|July 19, 2025
Personalized ctDNA monitoring in metastatic HR+/HER2- breast cancer patients during endocrine and CDK4/6 inhibitor therapyJesús Fuentes-Antrás, Mitchell J Elliott, Sasha C Main, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 9, 2025
Ultrasensitive Detection and Monitoring of Circulating Tumor DNA Using Structural Variants in Early-Stage Breast CancerMitchell J Elliott, Karen Howarth, Sasha Main, et al.
Pageof 2